skip navigation
NIH Record  
Vol. LXVII, No. 1
  January 2, 2015
NIH Observes Domestic Violence, Bullying Awareness Month
NIH Proposes Master Plan for Bethesda Campus
NIMHD Competitive Course Seeks to Define the Science of Health Disparities
printer friendly version
‘Guided by Science’
President Obama Visits NIH, Touts Progress in Ebola Vaccine Effort

President Obama at NIH Dec. 2
President Obama at NIH Dec. 2
In his Dec. 2 visit to NIH, President Barack Obama revealed two things about his approach to problem-solving: The U.S. will respond with compassion and science will lead the way. He used his time at what he calls “America’s laboratory” to congratulate scientists for delivering a potential Ebola vaccine and to champion scientific research once again as the nation’s most powerful weapon against global health threats.

“We are going to be guided by the science—not by speculation, not by fear, not by rumor, not by panic—by science,” said President Obama, in a 22-minute address to a packed Masur Auditorium. Earlier he had visited two NIAID senior investigators (see sidebar) and their labs in the Vaccine Research Center. With the briefings in Bldg. 40 and the speech in the Clinical Center, he spent about 90 minutes on campus.

“One of the things that has always marked us as exceptional is our leadership in science and our leadership in research,” the President said. “Here at NIH, you have always been at the forefront of groundbreaking innovations.”


‘A Hot One’
ACD Highlights Support for IRP, Deems NCS Infeasible

NIH director Dr. Francis Collins (l) at ACD
NIH director Dr. Francis Collins (l) at ACD
Not all biannual meetings of the advisory committee to the NIH director (ACD) are created equal, and the 109th version, held Dec. 11-12, lived up to NIH director Dr. Francis Collins’s prediction that it would be “a hot one.” Amid a welter of reports drawing impassioned comments, the NIH Intramural Research Program gained a hearty endorsement while the embattled National Children’s Study was closed down in favor of more nimble and focused investments to achieve its aims.